Rights Issue14 Aug 2026, 11:00 pm
iSERA Lifesciences Submits Rights Issue Proceeds Utilization Report
AI Summary
iSERA Lifesciences Limited (formerly Covidh Technologies Limited) has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of proceeds from its Rights Issue. The report, issued by Infomerics Valuation and Rating Private Limited, confirms no deviation from the objects for which the funds were raised. The Rights Issue aggregated to ₹8.08 crore. The company and the monitoring agency have declared that the report provides an objective view of the utilization of funds.
Key Highlights
- Monitoring Agency Report submitted for Rights Issue proceeds utilization.
- No deviation reported in the utilization of funds for the quarter ended June 30, 2026.
- Rights Issue aggregated to ₹8.08 crore.
- Report issued by Infomerics Valuation and Rating Private Limited.
- Company formerly known as Covidh Technologies Limited.
Price Impact
More from COVIDH